ublished: Jun 27, 2024 04:50:24 PM
Sequence No.: 18
ISIN: US4312882081

Hikma Pharmaceuticals PLC

Director Declaration

- ENDS -

 

Enquiries:

 

Hikma Pharmaceuticals PLC
Helen Middlemist Group Company Secretary